United Therapeutics Corp (UTHR) Reports Q4 EPS of $0.79, Reaffirms FY12, FY13 Guidance
Go back to United Therapeutics Corp (UTHR) Reports Q4 EPS of $0.79, Reaffirms FY12, FY13 Guidance| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 499.73 -1.54 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $501.27 | 52 Week High | $164.04 | |||
| Open | $498.91 | 52 Week Low | $97.52 | |||
| Day High | $501.62 | P/E | 91.36 | |||
| Day Low | $494.35 | EPS | $5.47 | |||
| Volume | 355,668 | |||||
